Building a community-based system to detect and respond to respiratory viruses in Seattle.
IP24-045, SEAPREP: Seattle Pandemic Preparedness Cohort
This study is looking for 2,000 people, both kids and adults, to help us learn more about how respiratory viruses spread in homes by checking in on their health each week and collecting samples, so we can be better prepared for future outbreaks.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11037585 on NIH RePORTER |
What this research studies
This research focuses on creating a community-based surveillance system to detect respiratory viruses early, which can help inform public health responses. It involves a longitudinal study of 2000 participants, including children and adults, who will undergo weekly symptom screenings and provide biospecimens for testing. The study aims to enhance our understanding of how respiratory viruses spread within households and improve preparedness for future pandemics. The team includes experts in various fields such as infectious diseases and epidemiology, ensuring a comprehensive approach to the research.
Who could benefit from this research
Good fit: Ideal candidates for participation include children and adults living in the Seattle area who are willing to undergo regular health screenings.
Not a fit: Patients outside the Seattle area or those not interested in participating in regular health monitoring may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and management of respiratory virus outbreaks, ultimately protecting public health.
How similar studies have performed: Previous community-based surveillance efforts during the SARS-CoV-2 pandemic have demonstrated the effectiveness of early detection and response strategies.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Chu, Helen Ying-Hui — University of Washington
- Study coordinator: Chu, Helen Ying-Hui
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.